Neogen Chemicals Limited — Investor Meet, 09-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Neogen Chemicals Q2 FY26 consolidated revenue rose 8% YoY to ₹208.7 Cr, with half-year revenue up 6%. Q2 PAT, however, dropped 69% to ₹3.4 Cr due to higher operating/insurance costs and finance charges for expansion and rebuilding. Management cited operational resilience and sustained core business. Strategic focus on high-growth battery materials continues, with commercial electrolyte supply started. Key expansions are on track; ₹200 Cr was raised via NCDs for growth. Dahej plant rebuild progresses, expected next year. Company is confident in long-term growth from technology and battery materials, with H2 typically stronger.